"Does creatine help while cutting" is one of the most-asked questions in supplement use. The randomised evidence that speaks to it directly consists of two trials, and they point in opposite directions.
Counting what exists
A PubMed search for creatine supplementation crossed with energy restriction, caloric restriction, weight loss or fat loss returns 70 records. Filtering to the randomised-controlled-trial publication type leaves two.
That is the first finding and it is worth sitting with. The surrounding 68 records are reviews, position statements, observational work and trials in which weight was a secondary measurement. For a question this common, the direct literature is two small studies.
Trial one: no effect at all
Fifteen women in early rehabilitation after bariatric surgery were randomised, double-blind, to 8 g of creatine or placebo before each of three weekly strength-training sessions for eight weeks.
| Over 8 weeks | Creatine (n = 7) | Placebo (n = 8) |
|---|---|---|
| Body weight | −9.5 ± 1.5 kg | −9.6 ± 3.5 kg |
| Muscle mass | −0.72 ± 0.6 kg | −0.6 ± 1.2 kg |
| Fat mass | −8.64 ± 1.2 kg | −8.88 ± 3.2 kg |
No difference reached significance on any measure. The authors' own conclusion is that pre-session creatine was not superior to placebo for attenuating muscle-mass loss during the first weeks of rehabilitation.
Two things limit it. Fifteen people is a very small trial, and losing 9.5 kg in eight weeks after bariatric surgery is not the situation most people mean by cutting.
Trial two: an effect
Sixty-four healthy sedentary adults aged 45 to 65 took 2 × 5 g a day of creatine monohydrate or a maltodextrin placebo for 12 weeks, with body composition measured by dual-energy X-ray absorptiometry at weeks 0, 6 and 12. Creatine taken during an exercise and weight-loss diet intervention increased lean tissue mass, produced a greater reduction in body fat percentage, and improved muscular strength and endurance. It is registered as ISRCTN83081058.
That is a better-instrumented trial than the first, and two features belong next to the result. Participants selected for themselves whether to enter the exercise-and-diet arm or the non-exercise arm; randomisation to creatine or placebo happened inside that self-selected group, so the deficit was not randomised. And the senior author discloses having conducted industry-sponsored creatine research — disclosed in the paper, which is where this comes from.
The problem neither trial solves
Both used body-composition methods that count body water inside the lean compartment. Creatine reliably increases intracellular water: in a separate year-long trial in haemodialysis patients, a fat-free-mass increase travelled with total body water rising from 35.4 to 36.1 litres, driven by the intracellular compartment going from 20.2 to 21.0 litres.
So a lean-mass gain measured during energy restriction is consistent with two different stories — tissue preserved, or fluid added — and neither trial measured the compartments separately. The methods that can do it are the ones we followed through on what creatine does to body water, and no trial of creatine during a deficit has used them.
This also means the scale is the least informative instrument available during a cut on creatine, and body-fat percentages derived from impedance are not much better.
Where the body-mass effect is simply a cost
There is one setting where the trade-off is not ambiguous.
A 2025 narrative systematic review of creatine in combat-sport athletes — wrestling, judo, taekwondo, boxing — included 19 studies. It reported that creatine increased body mass, most clearly in interventions of six weeks or longer or combined with structured resistance training, alongside increases in fat-free mass and improvements in muscular power and maximal strength.
For an athlete who must make a stated number on a scale before competing, added body mass is the cost of admission for those strength improvements, and the review does not resolve which side wins. It is the clearest illustration available that "does creatine help while cutting" is really two questions — what it does to the body, and what it does to the number the sport measures — and that the answers can point opposite ways.
What can honestly be said
- The direct randomised evidence is two small trials that disagree, one null in 15 post-surgical women, one positive in 64 middle-aged adults whose deficit arm was self-selected.
- Creatine's well-documented effect on scale weight and lean-mass readings runs partly through water, and no trial in a deficit has measured the compartments separately.
- In weight-category sport the body-mass increase is a straightforward cost, documented across 19 studies.
Anyone claiming this is settled is working from the surrounding 68 records rather than the two trials. For the other creatine questions that turn on the same water mechanism, see creatine and bloating, what the loading studies measured and creatine timing; for the safety literature, creatine's side effects and creatine and the kidneys.
This is research journalism. Amounts are reported with their sources and dates. Nothing here is a recommendation.
Sources
- Diaz-Pizarro M, Pino-Zúñiga J, Gálvez MO, et al. Creatine supplementation prior to strength exercise training is not superior in preventing muscle mass loss compared with standard nutritional recommendations after bariatric surgery. 2024 — PMID 39251568
- Chun J, Liu Y, Kibler GL, et al. Effects of creatine supplementation with and without exercise and diet intervention on body composition, cognitive function, and markers of health in middle-aged and older adults. J Int Soc Sports Nutr 2026;23(sup1):2716273 — PMID 42578920 · PMC13463452 · registry ISRCTN83081058
- Creatine supplementation in combat sport athletes: a narrative systematic review. 2025 — PMID 40755023
- Marini ACB, Schincaglia RM, Candow DG, Pimentel GD. Effect of creatine supplementation on body composition and Malnutrition-Inflammation Score in hemodialysis patients. Nutrients 2024;16(5):615 — PMID 38474743
